Department of Obstetrics and Gynecology, University of Cincinnati, Cincinnati, Ohio, USA.
Diabetes. 2010 May;59(5):1161-70. doi: 10.2337/db09-0824. Epub 2010 Feb 11.
Maternal adiponectin levels are reduced and placental nutrient transporters are upregulated in obesity and gestational diabetes mellitus; however, the effects of adiponectin on placental function are unknown. We hypothesized that adiponectin regulates placental amino acid transport.
Human primary trophoblast cells were cultured and incubated with globular adiponectin (gAd) or full-length adiponectin (fAd) alone or in combination with insulin. System A and L amino acid transport and SNAT1, SNAT2, and SNAT4 isoform expression was measured. The activity of the AMP-activated protein kinase (AMPK), phosphatidylinositol 3 kinase-AKT, and peroxisome proliferator-activated receptor-alpha (PPARalpha) signaling pathways was determined.
In the absence of insulin, gAd stimulated AMPK Thr172 phosphorylation, SNAT2 protein expression, and system A activity. This effect appeared to be mediated by interleukin-6 release and signal transducer and activator of transcription 3 (STAT3) signaling because gAd failed to stimulate system A in cells in which STAT3 had been silenced using small interfering RNA. fAd alone had no effect on system A activity or SNAT expression. Insulin increased AKT and insulin receptor substrate 1 (IRS-1) phosphorylation, system A activity, and SNAT2 expression. When combined with insulin, gAd did not affect system A activity or SNAT expression. In contrast, fAd abolished insulin-stimulated AKT Thr308 and IRS-1 Tyr612 phosphorylation, system A activity, and SNAT2 expression. Furthermore, fAd increased PPARalpha expression and PPARalpha (Ser21) phosphorylation.
In contrast to the insulin-sensitizing actions of adiponectin in liver and muscle reported in the literature, fAd attenuates insulin signaling in primary human trophoblast cells. As a result, fAd inhibits insulin-stimulated amino acid transport, which may have important implications for placental nutrient transport and fetal growth in pregnancy complications associated with altered maternal adiponectin levels.
肥胖症和妊娠期糖尿病患者的母源脂联素水平降低,胎盘营养转运体上调;然而,脂联素对胎盘功能的影响尚不清楚。我们假设脂联素调节胎盘氨基酸转运。
人原代滋养层细胞培养并与球形脂联素(gAd)或全长脂联素(fAd)孵育,单独或与胰岛素一起孵育。测量系统 A 和 L 氨基酸转运以及 SNAT1、SNAT2 和 SNAT4 同工型的表达。测定 AMP 激活的蛋白激酶(AMPK)、磷酸肌醇 3 激酶-AKT 和过氧化物酶体增殖物激活受体-α(PPARα)信号通路的活性。
在没有胰岛素的情况下,gAd 刺激 AMPK Thr172 磷酸化、SNAT2 蛋白表达和系统 A 活性。这种作用似乎是由白细胞介素 6 释放和信号转导和转录激活因子 3(STAT3)信号介导的,因为在使用小干扰 RNA 沉默 STAT3 的细胞中,gAd 未能刺激系统 A。fAd 单独对系统 A 活性或 SNAT 表达没有影响。胰岛素增加 AKT 和胰岛素受体底物 1(IRS-1)磷酸化、系统 A 活性和 SNAT2 表达。当与胰岛素联合使用时,gAd 不影响系统 A 活性或 SNAT 表达。相比之下,fAd 消除了胰岛素刺激的 AKT Thr308 和 IRS-1 Tyr612 磷酸化、系统 A 活性和 SNAT2 表达。此外,fAd 增加了 PPARα 的表达和 PPARα(Ser21)磷酸化。
与文献中报道的脂联素在肝脏和肌肉中的胰岛素增敏作用相反,fAd 减弱了原代人滋养层细胞中的胰岛素信号。因此,fAd 抑制了胰岛素刺激的氨基酸转运,这可能对与母体脂联素水平改变相关的妊娠并发症中的胎盘营养转运和胎儿生长具有重要意义。